ArabFinance: Sabaa International for Pharmaceutical and Chemical Industry (SIPC) reported a 264% Year on Year growth in its consolidated net profit for the first nine months of 2020, according to the company’s financial statements filed to the Egyptian Exchange.

Net profit stood at EGP 6,701,518 in the January-September period of 2020, compared to EGP 1,826,565 achieved in the prior-year period.

Sabaa expects to produce two medicines to treat coronavirus before the end of this year.

The Egypt-based company is engaged in the pharmaceutical sector, with a generic product portfolio that includes products focused on different therapeutic categories.